newsfilter
← Latest News
GlobeNewswire·

NextCure Provides Business Update and Reports First Quarter 2024 Financial Results

Phase 1b data for NC410 combo with pembro to be presented at ASCO annual meeting on June 1Presented preclinical data from LNCB74 (B7-H4 ADC) at recent AACR annual meeting Cash of approximately $96.0 million expected to